Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MallinckrodtFulcrum TherapeuticsCatalyst PharmaceuticalsAnaptysBioAtreca
SymbolNYSE:MNKNASDAQ:FULCNASDAQ:CPRXNASDAQ:ANABNASDAQ:BCEL
Price Information
Current Price$4.49$15.20$4.77$15.29$20.98
52 Week RangeHoldBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldBuy
Consensus Price Target$8.64$23.00$9.75$79.25$24.41
% Upside from Price Target92.49% upside51.32% upside104.40% upside418.31% upside16.34% upside
Trade Information
Market Cap$377.58 million$354.78 million$491.55 million$414.82 million$586.60 million
Beta2.64N/A2.471.19N/A
Average Volume7,456,50466,2141,421,828502,591216,663
Sales & Book Value
Annual Revenue$3.22 billionN/A$500,000.00$5 millionN/A
Price / Sales0.12N/A983.1082.96N/A
Cashflow$18.71 per shareN/AN/AN/AN/A
Price / Cash0.24N/AN/AN/AN/A
Book Value$34.66 per shareN/A$0.49 per share$18.18 per shareN/A
Price / Book0.13N/A9.730.84N/A
Profitability
Net Income$-3,607,000,000.00$-32,590,000.00$-34,000,000.00$-61,660,000.00N/A
EPS$8.01N/A($0.33)($2.50)N/A
Trailing P/E RatioN/A0.0059.63N/A0.00
Forward P/E Ratio0.66N/A10.15N/AN/A
P/E Growth$0.05N/AN/AN/AN/A
Net Margins-111.44%N/A12.99%N/AN/A
Return on Equity (ROE)24.36%N/A15.53%-20.63%N/A
Return on Assets (ROA)7.01%-88.08%12.74%-19.45%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.64%N/A0.01%N/AN/A
Current Ratio1.07%12.26%5.04%14.28%27.38%
Quick Ratio0.86%12.26%5.00%14.28%27.38%
Ownership Information
Institutional Ownership Percentage90.96%66.17%64.52%96.93%57.54%
Insider Ownership Percentage2.70%N/A10.70%14.00%N/A
Miscellaneous
Employees3,70062517885
Shares Outstanding84.09 million23.34 million103.05 million27.13 million27.96 million
Next Earnings Date2/25/2020 (Estimated)N/A3/16/2020 (Estimated)2/27/2020 (Estimated)2/18/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel